Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (TargetAMD)

Tools

Item Type:	Article
Title:	Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (TargetAMD)
Creators Name:	Thumann, G., Perdikomati-Dahmen, M., Izsvák, Z., Ivics, Z., Garcia Layana, A., Ronchetti, M., Petrovski, G., Scherman, D., Aranda, P., Pouillot, S., Binder, S., Johnen, S. and van den Berg, J.
Keywords:	Cell Line, DNA Transposable Elements, Eye Proteins, Genetic Therapy, Iris, Macular Degeneration, Nerve Growth Factors, Pigment Epithelium of Eye, Retina, Serpins, Animals, Cattle
Source:	Human Gene Therapy Clinical Development
ISSN:	2324-8637
Publisher:	Mary Ann Liebert
Volume:	26
Number:	2
Page Range:	97-100
Date:	18 June 2015
Additional Information:	Zsuzsanna Izsvak is a partner of the TargetAMD consortium.
Official Publication:	https://doi.org/10.1089/humc.2015.2519
PubMed:	View item in PubMed

Repository Staff Only: item control page